About the Journal

Hepatoma Research (HR) is an international peer-reviewed, open access, online journal.

Aims and Scope

The journal focuses on all topics related to hepatoma, including its occurrence, development, diagnosis, and treatment. The coverage also extends to other basic and clinical studies related to surgery, internal medicine, cell biology, pathology, pathophysiology, immunology, genetics, pharmacology, etc.

    Articles in the following areas are especially welcome:
  • Pathogenesis, clinical examination, and diagnosis of hepatomas;
  • Surgery, internal medicine, molecular biology, cell biology, pathology, pathophysiology, immunology, genetics, pharmacology, and other research areas related to hepatoma;
  • Treatments of hepatoma, including basic and clinical research on animal models, liver transplantation, molecular targeted therapy, interventional therapy, hepatoma treatment-related drugs, as well as clinical transition of the latest laboratory therapy;
  • Complications of hepatoma and their prevention and treatment.

The journal publishes the following types of articles: Review Article, Original Article, Case Report, Commentary, Editorial, Research Highlight, etc. Manuscripts with videos are welcome.


The journal is owned by OAE Publishing Inc.

Open Access

All articles published by HR are made freely and permanently accessible online immediately from the date of publication. For further information, please refer to Open Access. Articles had been published under Attribution-NonCommercial-ShareAlike 3.0 Unported till October 2017, whereas the Attribution 4.0 International (CC BY 4.0) was further adopted afterwards. The CC BY allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license users are free to share (copy, distribute and transmit) and remix (adapt) the contribution for any purposes, even commercially, provided that the users appropriately acknowledge the original authors and the source.
Authors retain the copyright of their works as well as the rights to make certain uses of the works.

Editorial Board

For more information about the editorial team, please refer to Editorial Board.

Editorial Policies

All manuscripts submitted to HR should adhere to OAE's Editorial Policies.

Peer Review

The journal adheres to rigorous peer review process and undergoes single-blind peer review. For more details, please refer to Editorial Process and Peer Review Guidelines.

Publication Ethics Statement

Hepatoma Research is a member of the Committee on Publication Ethics (COPE). We fully adhere to its Code of Conduct and to its Best Practice Guidelines.

The editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to ensure to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The editors of Hepatoma Research take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use CrossCheck (powered by iThenticate) to check submissions against previous publications.

Journal Information and Statistics

  • Launch date: April 15, 2015
  • Publication model: Open access
  • Online ISSN: 2454-2520
  • Print ISSN: 2394-5079
  • Digital archive: Portico 
  • Frequency: Continuously published
  • DOI: 10.20517/2394-5079


    All articles published in HR are included in:
  • CAS
  • CNKI
  • DRJI
  • Eurasian Scientific Journal Index
  • Google Scholar
  • JournalGuide
  • JournalTOCs
  • Open J-Gate
  • ResearchBib
  • Root Indexing
  • Wanfang Data


Please visit the Contact Us for details about different queries.